StockNews.com Begins Coverage on Avinger (NASDAQ:AVGR)

StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a research report report published on Wednesday. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Trading Down 1.9 %

Shares of NASDAQ AVGR opened at $0.54 on Wednesday. The firm has a market capitalization of $1.79 million, a P/E ratio of -0.05 and a beta of 1.15. The firm’s 50-day moving average price is $0.74 and its 200-day moving average price is $0.97. Avinger has a 1-year low of $0.39 and a 1-year high of $5.45.

Avinger (NASDAQ:AVGR) last posted its quarterly earnings results on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.03) by $0.21. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. The business had revenue of $1.65 million for the quarter, compared to the consensus estimate of $1.60 million. During the same period in the prior year, the business earned ($2.92) EPS. Equities research analysts forecast that Avinger will post -4.69 EPS for the current year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.